Spiga

PhD/ Postdoctoral– Position on recombinant proteins/ Influenza virus

The Max-Planck-Institute for Dynamics of Complex Technical Systems and the Otto-von Guericke University invites applications for 2 PhD/ Postdoctoral positions in downstream processing of biologicals.

The project will be co-funded by the German Federal Ministery of Science (BMBF) and the pharmaceutical industry.

One position focuses on the development of an affinity chromatography for the purification of pharmaceutically relevant recombinat proteins. In the study, chip based binding studies via Biacore, ELISA and classical downstream methods as well as membrane adsorber techniques will be applied to optimize the purification process of cell culture derived recombinant glycoproteins.

The other position aims at the development of an SMB purification process for cell-culture derived Influenza viruses and viral glycoproteins.

We offer an excellent multidisciplinary team-oriented research environment and opportunities. The projects will be executed in a close cooperation with the pharmaceutical industry.
We are looking for three post-doctoral scientists or PhD students with a degree in Biotechnology or Engineering, keen to apply cutting edge research and technology to start the dissolving of current bottle necks in downstream processes. The positions are intended to start October 2008 and are for a period of 3 years.
Excellent communication skills in English are required. Experiences in chromatography as well as an interest in mathematical modeling are advantages.

Women are explicitly encouraged to apply for the described positions. Disabled people will be favored in the case of identical competence and performance. Please mention that you accept the involvement of the equal-opportunity representative in the selection procedure.

For more information please refer to Dr. Michael Wolff (Tel.: + 49 391 6 11 02 31). If interested please email a short application including CV, certificates and three references to mwolff@mpi-magdeburg.mpg.de.

September 25, 2008